Ischemic brain stroke is a leading cause of morbidity and mortality, resulting from the obstruction of blood flow to the brain, typically due to thrombosis or embolism. This interruption leads to neuronal death and subsequent deficits in motor function, sensory function, speech, and cognition, depending on the affected brain regions. The pathophysiology involves local inflammation, oxidative stress, and the activation of apoptotic pathways, contributing to neurological impairment.

Stem cell therapy offers a promising approach for ischemic brain stroke recovery by promoting neurogenesis and repairing damaged neural networks. Stem cells can release neurotrophic factors that support neuronal survival and regeneration, as well as modulate inflammatory responses to minimize secondary damage. This innovative treatment aims to enhance functional recovery and improve the overall quality of life for stroke survivors.

The Regentime procedure for Ischemic Brain Stroke entails a 5-day program in Lebanon, with costs ranging from 22,500 USD to 32,000 USD.